Earle A. Chiles Research Institute Revenue and Competitors
Estimated Revenue & Valuation
- Earle A. Chiles Research Institute's estimated annual revenue is currently $3.6M per year.
- Earle A. Chiles Research Institute's estimated revenue per employee is $71,808
Employee Data
- Earle A. Chiles Research Institute has 50 Employees.
- Earle A. Chiles Research Institute grew their employee count by 22% last year.
Earle A. Chiles Research Institute's People
Name | Title | Email/Phone |
---|
Earle A. Chiles Research Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.1M | 20 | -26% | N/A | N/A |
#2 | $13.8M | 126 | 1% | N/A | N/A |
#3 | $17.2M | 151 | 6% | N/A | N/A |
#4 | $5.4M | 59 | 0% | N/A | N/A |
#5 | $5.8M | 61 | 5% | N/A | N/A |
#6 | $4M | 52 | 16% | N/A | N/A |
#7 | $2.1M | 28 | 4% | N/A | N/A |
#8 | $2.9M | 31 | -6% | N/A | N/A |
#9 | $87.2M | 684 | 13% | N/A | N/A |
#10 | $5M | 60 | 5% | N/A | N/A |
What Is Earle A. Chiles Research Institute?
The Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute is a world-class research facility located within Providence Cancer Center in Portland, Ore. Founded in 1993 by Walter Urba, M.D., Ph.D., director of cancer research, and a team of internationally-recognized scientists, our main area of investigation is cancer immunotherapy, a specialized field of study focused on harnessing the innate power of the immune system to cure cancer. The Earle A. Chiles Research Institute garners more than $4 million annually in federal and other sponsored grant funding and has a research staff of more than 100 team members.
keywords:N/AN/A
Total Funding
50
Number of Employees
$3.6M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.5M | 50 | -9% | $2.2M |
#2 | $10.4M | 50 | 9% | N/A |
#3 | $3.8M | 50 | 22% | N/A |
#4 | $14.8M | 50 | 4% | $26M |
#5 | $11.7M | 50 | -7% | N/A |